Target intelligence / Profile preview

RNA, U6 small nuclear 1317, pseudogene (RNU6-1317P)

Target
RNU6-1317P
Molecular classification
Other (snRNA pseudogene)
01

Overview

RNU6-1317P is a pseudogene copy of the U6 small nuclear RNA (snRNA) gene. U6 snRNA itself is a highly conserved small nuclear non-coding RNA involved in the spliceosomal excision of introns from pre-mRNA during mRNA splicing in eukaryotes[1][3]. However, RNU6-1317P is a pseudogene—a non-functional, non-protein-coding genomic sequence that resembles the functional U6 snRNA gene but typically does not produce a functional RNA or protein product[4]. U6 snRNA pseudogenes, such as RNU6-1317P, usually arise through retrotransposition processes facilitated by LINE-1 elements and are often dispersed throughout the genome as non-functional relics[4]. In general, pseudogenes like RNU6-1317P do not possess any known biological activity, are not drug targets, and have no established roles in disease or therapy. Their primary scientific relevance is in studies of genome evolution and retrotransposition dynamics[4]. Key caveat: This gene is not a receptor, enzyme, transporter, or any molecule type typically targeted in therapeutic settings. It lacks functional RNA production and is considered non-functional. Its only relevance is as a marker in genomics rather than in cell biology, pathophysiology, or pharmacology[4]. Summary: RNU6-1317P corresponds to a pseudogene of U6 snRNA, has no known function, is not therapeutically relevant, and should not be considered a canonical target for drugs or biological research beyond studies of pseudogene formation[4].

Other names
RNU6-1317PRNA, U6 small nuclear 1317, pseudogene
02

Mechanism of action

None

03

Biological functions

None (pseudogene; presumed non-functional)
04

Disease associations

None (no established roles in disease)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1317, pseudogene (RNU6-1317P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1317, pseudogene (RNU6-1317P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call